Common Contracts
7 similar Employment Agreement contracts by In8bio, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2024 • In8bio, Inc. • Biological products, (no disgnostic substances)
This Employment Agreement (the “Agreement”) is entered into as of October 7, 2021 (the “Effective Date”), by and between Trishna Goswami, MD (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2024 • In8bio, Inc. • Biological products, (no disgnostic substances)
This Employment Agreement (the “Agreement”) is entered into as of March 14, 2024 (the “Effective Date”), by and between Kate M. Rochlin, PhD (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2024 • In8bio, Inc. • Biological products, (no disgnostic substances)
This Employment Agreement (the “Agreement”) is entered into as of January 20, 2021 (the “Effective Date”), by and between Patrick McCall (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • In8bio, Inc. • Biological products, (no disgnostic substances)
This Employment Agreement (the “Agreement”) is entered into as of January 20, 2021 (the “Effective Date”), by and between Patrick McCall (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • In8bio, Inc. • Biological products, (no disgnostic substances)
This Employment Agreement (the “Agreement”) is entered into as of October 7, 2021 (the “Effective Date”), by and between Trishna Goswami, MD (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2022 • In8bio, Inc. • Biological products, (no disgnostic substances)
This Employment Agreement (the “Agreement”) is entered into as of January 20, 2021 (the “Effective Date”), by and between Patrick McCall (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2022 • In8bio, Inc. • Biological products, (no disgnostic substances) • New York
This Employment Agreement (the “Agreement”) is entered into as of October 7, 2021 (the “Effective Date”), by and between Trishna Goswami, MD (the “Executive”) and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”) (Executive and the Company together, the “Parties”).
